History of GLP-1 drugs — complete timeline from exenatide (2005) through Ozempic, Wegovy, Mounjaro, Zepbound, and the 2026 pipeline | PlexusDx

History of GLP-1 Drugs: Complete Timeline From Exenatide (2005) to Tirzepatide and Beyond

The complete history of GLP-1 drugs — from 1902 incretin research to exenatide (2005), Victoza (2010), Ozempic (2017), Rybelsus (2019), Wegovy (2021), Mounjaro (2022), Zepbound (2023), and pipeline candidates orforglipron — with where PlexusDx Semaglutide, Tirzepatide, Microdose, and GLP-Squared protocols fit in 2026.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →
Rybelsus for weight loss in 2026 — FDA-approved use, real numbers, and how PlexusDx Semaglutide Oral compares

Rybelsus for Weight Loss (2026): What It Does, What It Doesn't, and Where PlexusDx Oral Semaglutide Fits

Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes only — not for weight loss. See the real PIONEER weight numbers, the ~$998/month cash price, why insurance rarely covers off-label use, and how PlexusDx Semaglutide Oral ($289/mo+) and the Microdose GLP-1 Protocol ($129/mo) compare on cost and dose flexibility.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →
Oral tirzepatide FDA status — what's approved, what's compounded, and how PlexusDx Tirzepatide Oral fits in 2026

Oral Tirzepatide FDA Status (2026): What's Approved, What's Compounded, and How PlexusDx Fits

Is oral tirzepatide FDA approved? No — only injectable Mounjaro and Zepbound are. Here's what compounded oral tirzepatide is, how PlexusDx Tirzepatide Oral ($349/mo) fits, and the safety considerations that apply to both.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →